Roughly half of people with diabetes who undergo a lower-limb amputation do not survive five years, according to pooled data from multiple studies that put the weighted five-year mortality at about 51%.1PubMed Central. Lower extremity amputations and long-term outcomes in diabetic foot ulcers: A systematic review That figure rivals or exceeds the mortality of several common cancers, and it has stubbornly remained high even as diabetes care has improved in other respects. But “how long” is never a single number. Whether the amputation was a toe or an above-knee procedure, whether the person is on dialysis, and whether they receive coordinated follow-up care can shift survival by years in either direction.
Survival at One, Three, Five, and Ten Years
A long-running follow-up study of patients with diabetic foot disease found survival rates of about 64% at one year, 50% at three years, 40% at five years, and just 24% at ten years. In other words, three out of four patients in that cohort had died within a decade of the amputation.2PubMed. Survival at 10 years following lower extremity amputations in patients with diabetic foot disease A systematic review pulling together data from multiple countries reported weighted mean mortality of about 14% at one year, 30% at three years, and 51% at five years, with higher rates tied to major amputation, repeat amputation, and heart disease.1PubMed Central. Lower extremity amputations and long-term outcomes in diabetic foot ulcers: A systematic review These numbers vary between studies, partly because the mix of patients differs: a study enrolling mostly younger people with toe amputations will look better than one enrolling mostly older people with above-knee procedures. But the overall picture is consistently grim.
How Mortality Compares to Cancer
One way to put these numbers in perspective is to stack them against diseases people already take seriously. A study that directly compared five-year mortality across conditions found that minor amputations carried a five-year mortality of about 46%, and major amputations about 57%. For comparison, five-year mortality for breast cancer was 9%, and the pooled five-year mortality for all reported cancers combined was 31%.3PubMed Central. Five year mortality and direct costs of care for people with diabetic foot complications are comparable to cancer Even diabetic foot ulcers that had not yet led to amputation carried a five-year mortality of about 31%, on par with cancer overall. These comparisons are not meant to minimize cancer but to challenge the common assumption that losing a toe or part of a foot is a manageable setback. Diabetic amputation is a marker of advanced systemic disease, and the prognosis reflects that.
Minor Versus Major Amputation
The level where the surgeon cuts makes a measurable difference. “Minor” generally means below the ankle, such as removing a toe or part of the forefoot. “Major” means below-knee or above-knee procedures. A review of the literature found that five-year survival after major amputation ranges from roughly 10% to 48%, while minor amputation five-year survival ranges from about 29% to 69%.4PubMed Central. Mortality Rates of Minor vs Major Lower Extremity Amputations in Diabetic Patients Short-term risk differs sharply, too: 30-day mortality after major amputation falls between roughly 8% and 15%, while it stays under 5% for minor amputations.
A population-based study in a developing country found one-year mortality of 33% for major amputations versus 18% for minor ones, and four-year mortality of 65% versus 45%.5BMJ Open. Survival and factors predicting mortality after major and minor lower-extremity amputations among patients with diabetes: a population-based study using health information systems A large national study of below-knee amputations in England reported 30-day mortality of about 7%, one-year mortality of roughly 25%, and five-year mortality of about 61% for diabetic patients.6Abstracts, 2025-Jan, Podium. Mortality, re-amputation and post operative complication rates following 28,000 below knee amputation in diabetic patients in England: a national population study 2002-2022 The wide ranges across studies reflect differences in patient populations, healthcare systems, and how aggressively underlying conditions are managed. But the consistent pattern is that the higher the amputation, the worse the outlook.
The 30-Day Window
The period right after surgery carries its own danger, separate from long-term survival. A study examining 30-day mortality across patients with and without diabetes found that it ranged from about 3.5% to 34% in diabetic patients, depending on the reason for amputation. The highest short-term mortality was in patients amputated for sepsis or other acute emergencies; in less urgent cases, 30-day mortality stayed under 10%.7PubMed Central. Amputations of Lower Limb in Subjects with Diabetes Mellitus: Reasons and 30-Day Mortality The cause driving the amputation matters as much as diabetes itself in this early window. A person whose foot infection spiraled into blood poisoning faces a fundamentally different short-term risk than someone undergoing an elective toe removal for a non-healing wound.
Why Amputation Predicts Shortened Life
The amputation itself is not what kills most patients. Losing a limb is a consequence of years of damage to blood vessels and nerves, and that same damage affects the heart, brain, and kidneys. The leading cause of death in most Western studies is cardiovascular disease: heart attacks and strokes.8PubMed. Mortality in diabetic patients after lower extremity amputations A Taiwanese follow-up study of diabetic amputees found that the underlying cause of death was recorded as diabetes itself in about 58% of cases, reflecting the way the disease attacks multiple organ systems simultaneously.9PubMed. Mortality, causes of death and associated risk factors in a cohort of diabetic patients after lower-extremity amputation
Peripheral artery disease, the narrowing of blood vessels that often precipitates amputation in the first place, is itself a powerful marker of widespread vascular disease. The most advanced form carries a high risk of both limb loss and cardiovascular death.10PubMed Central. Epidemiology and Risk of Amputation in Patients With Diabetes Mellitus and Peripheral Artery Disease A study comparing patients with diabetic foot syndrome, those with peripheral artery disease plus diabetes, and those with peripheral artery disease alone found that four-year survival was lowest in the diabetic foot group, at about 57%.11PubMed. Amputations and mortality in in-hospital treated patients with peripheral artery disease and diabetic foot syndrome The combination of diabetes and poor blood flow creates a reinforcing cycle where wounds do not heal, infections take hold, and the vascular damage that allowed the wound in the first place keeps doing damage elsewhere in the body.
Kidney Disease Changes the Timeline Dramatically
If any single factor stands out as a predictor of worse outcomes, it is kidney disease. Diabetes is the leading cause of kidney failure, and when both conditions reach advanced stages, the prognosis after amputation drops sharply. One study found that dialysis patients faced a roughly fourfold increase in the risk of death compared to diabetic amputees without kidney impairment, while those with chronic kidney disease short of dialysis had about a 46% higher risk.12PubMed Central. Impact of chronic kidney disease on survival after amputation in individuals with diabetes
Among diabetic patients on dialysis, the amputation rate is roughly ten times that of the broader diabetic population, and two-thirds of those patients die within two years of their first amputation.13PubMed. Nontraumatic lower extremity amputations in the Medicare end-stage renal disease population An interesting finding from another study was that amputation itself increased the risk of death roughly fourfold regardless of whether the patient had diabetes. The risk multiplier from amputation was the same in patients with and without diabetes, suggesting that once you reach the point of amputation on dialysis, the kidney disease is doing most of the damage.14Clinical Kidney Journal. Mortality after amputation in dialysis patients is high but not modified by diabetes status
A meta-analysis of mortality after minor amputation ranked the most consistent independent risk factors, and age came first, followed by chronic kidney disease, peripheral artery disease, and coronary artery disease.15PubMed. A meta-analysis of mortality after minor amputation among patients with diabetes and/or peripheral vascular disease For clinicians and patients alike, the state of the kidneys is one of the most important pieces of the survival puzzle.
Frailty Matters More Than Age Alone
Older age is consistently linked to worse outcomes, but researchers have found that frailty, a measure of overall physical reserve, may be even more informative than age by itself. A retrospective cohort study using a clinical frailty scale found that patients with moderate-to-severe frailty had more than four times the risk of death compared to those who were fit, even after accounting for other factors.16PubMed. Clinical frailty scale as a tool to predict outcomes after lower extremity amputation among patients with diabetes: A retrospective cohort study A separate study using a different frailty index found that it independently predicted three-year mortality after major amputation for chronic wounds.17The Journal of Foot and Ankle Surgery. The 5-Factor Modified Frailty Index Predicts Long-Term Mortality Following Major Lower Extremity Amputation for Chronic Wounds
Frailty is useful because it captures something that age does not: two 70-year-olds may have very different reserves of muscle, nutrition, and organ function. A frail 65-year-old may face worse odds than a robust 75-year-old. For patients and families trying to understand what to expect, the person’s overall condition going into surgery is as meaningful as the calendar year they were born.
Re-Amputation and the Risk of Losing More
Many patients who undergo one amputation eventually need another. A retrospective study of patients amputated for diabetes or peripheral artery disease found a re-operation rate of about 34%, with the median time from first surgery to second surgery being roughly six weeks. Among the patients who died, the median survival after the initial amputation was about six months. However, the re-amputation itself did not appear to independently worsen survival beyond the risk already associated with the initial procedure.18Marmara Medical Journal. Does re-amputation following lower extremity amputation in diabetic or dysvascular patients negatively affect survival? That finding suggests it is the underlying disease burden, not the number of surgical events, that drives mortality. Still, each additional surgery carries its own risks of infection and complications, and losing more of the limb affects mobility and independence.
What Can Improve Survival
The numbers are bleak, but they are averages that include patients with advanced disease and limited care. Several interventions have been shown to improve outcomes, sometimes substantially.
Restoring Blood Flow
Revascularization, procedures that reopen or bypass blocked arteries, can improve both limb survival and overall survival. A cohort study of diabetic patients with critical limb ischemia found that the absence of revascularization was an independent predictor of death, roughly doubling the risk even after adjusting for other factors like age and heart disease.19European Journal of Vascular and Endovascular Surgery. Early and Five-year Amputation and Survival Rate of Diabetic Patients with Critical Limb Ischemia: Data of a Cohort Study of 564 Patients Another study found that when patients with diabetes did receive revascularization, their five-year limb salvage rate (about 87%) and survival rate (about 58%) were virtually identical to those of non-diabetic patients who received the same procedure.20JAMA Surgery. Lower Extremity Revascularization in Diabetes: Late Observations The message: diabetes does not inherently doom revascularization to failure. When the arteries can be repaired, the playing field levels out considerably.
Multidisciplinary Foot Care Teams
Coordinated care by teams that bring together vascular surgeons, podiatrists, wound specialists, and endocrinologists has one of the strongest evidence bases for preventing amputation in the first place. A systematic review of 33 studies found that 94% reported a decrease in major amputations when multidisciplinary teams were involved, with some centers achieving reductions of more than 50%.21PubMed Central. A Systematic Review of Multidisciplinary Teams to Reduce Major Amputations for Patients with Diabetic Foot Ulcers And these benefits extend beyond just preventing surgery. A study tracking patients with diabetic foot infections over eight years found that overall survival improved from about 23% to about 38% after a multidisciplinary team model was introduced, a relative improvement of 67%.22Journal of Diabetes and its Complications. Multidisciplinary management of diabetic foot infection associated with improved 8-year overall survival A smaller UK study echoed these trends, with major amputations dropping from 11% to 6% and three-year mortality falling from 39% to 29% after introducing a dedicated foot care clinic.23PubMed Central. Improving Diabetic Foot Care Through a Multidisciplinary Clinic: Experience From Pilgrim Hospital, UK
Prosthetic Fitting and Rehabilitation
What happens after the amputation matters for survival, not just quality of life. A study of patients who underwent major lower-limb amputation found that those who were fitted with a prosthesis had a dramatically lower risk of dying within the first year and within three years. After adjusting for age, other health conditions, and procedural factors, prosthetic fitting was associated with about a 76% lower likelihood of death at one year.24PubMed. Prosthetic fitting and mortality after major lower extremity amputation This does not mean the prosthesis itself is a magic treatment. People healthy enough to use a prosthesis are healthier to begin with. But the relationship also likely runs in the other direction: regaining mobility helps patients stay active, maintain cardiovascular fitness, and avoid the downward spiral of immobility. The finding underscores the importance of rehabilitation as part of post-amputation care rather than treating the surgery as the endpoint.
Depression as an Overlooked Risk Factor
Mental health rarely makes it into conversations about amputation prognosis, but emerging research suggests it should. Diabetes-related amputation depression and distress has been identified as a potentially dangerous complication in its own right.25Seminars in Vascular Surgery. Diabetes-Related Extremity Amputation Depression and Distress (DREADD): A Multimethod Study A prospective study found that depression scores before surgery were a significant predictor of early mortality. Among patients with high depression scores, 45% died, compared to about 5% of those with lower scores. A depression score above a certain threshold predicted mortality with 90% sensitivity.26The Journal of Foot and Ankle Surgery. Depression as a Prognostic Factor in Lower Extremity Amputation for Diabetic Foot: Insights From a Prospective Study on Wound Healing, Infections, and Early Mortality
The mechanisms connecting depression to death are not fully mapped, but some pathways are plausible. Depressed patients are less likely to manage blood sugar carefully, attend follow-up appointments, participate in rehabilitation, or maintain nutrition. Depression also alters the stress response and immune function. Whatever the pathways, the size of the effect is hard to ignore, and it suggests that screening for depression before and after amputation could be a practical way to identify patients at highest risk.
Racial and Geographic Disparities
Where you live and who you are should not affect your odds of surviving a diabetic foot complication, but the data say otherwise. A study of Medicare beneficiaries hospitalized with diabetic foot ulcers found that rural patients identifying as White had about a 14% higher odds of major amputation or death compared with their urban counterparts. For rural patients identifying as Black, the odds jumped by more than 80% compared with urban Black patients. The interaction between rural residence and Black race was significant and amplifying, meaning the two factors together were worse than either alone would predict.27JAMA Network Open. Association of Race, Ethnicity, and Rurality With Major Leg Amputation or Death Among Medicare Beneficiaries Hospitalized With Diabetic Foot Ulcers
These disparities reflect differences in access to vascular specialists, wound care centers, and the multidisciplinary teams that have been shown to reduce amputations and improve survival. A patient in a rural area without a nearby vascular surgeon may receive an amputation that a patient in an urban academic medical center would have avoided through revascularization. The survival numbers discussed throughout this article are averages; for patients in underserved communities, the real numbers are likely worse.
Newer Medications Showing Promise
Two newer classes of diabetes drugs have attracted attention not just for blood sugar control but for their effects on cardiovascular and limb outcomes. A nationwide retrospective cohort study comparing GLP-1 receptor agonists with SGLT2 inhibitors in patients with type 2 diabetes found that GLP-1 receptor agonists were associated with a lower risk of major amputation, minor amputation, diabetic foot ulcers, and overall mortality. The mortality reduction was about 34%, and the risk reduction for major amputation held up even in patients who already had peripheral artery disease or diabetic foot ulcers.28Diabetes Care. Differential Effect of GLP-1 Receptor Agonists and SGLT2 Inhibitors on Lower-Extremity Amputation Outcomes in Type 2 Diabetes: A Nationwide Retrospective Cohort Study This is a retrospective comparison rather than a randomized trial, so the findings need to be interpreted with some caution. But they suggest that the choice of diabetes medication may influence limb outcomes and survival in ways that go beyond glucose numbers. For patients already at risk of foot complications, these data give clinicians and patients something concrete to discuss when choosing between treatment options.
What a Below-Knee Amputation Specifically Looks Like
Because below-knee amputation is one of the most common major procedures in diabetic foot disease, it is worth drilling into its numbers separately. A study of 470 patients who underwent below-knee amputation found a 90% survival rate at seven days, 84% at 30 days, and 64% at one year. The median post-surgical life expectancy was roughly 930 days, or about two and a half years. By the time of the study’s completion, about 71% of patients had died.29PubMed Central. Factors affecting lifespan following below-knee amputation in diabetic patients The factors that predicted worse outcomes in this group were consistent with the broader literature: hemodialysis treatment, older age, and longer duration of insulin use all pointed to higher mortality. Being on dialysis and being male carried particularly strong associations with earlier death.
A large English national study of roughly 28,000 below-knee amputations in diabetic patients found a similar trajectory, with about a quarter dead at one year and roughly 61% dead at five years.6Abstracts, 2025-Jan, Podium. Mortality, re-amputation and post operative complication rates following 28,000 below knee amputation in diabetic patients in England: a national population study 2002-2022 The consistency between these studies, conducted in different countries with different healthcare systems, suggests the numbers are fairly reliable for this particular procedure.
How Patients and Families Can Use These Numbers
Statistics about survival after amputation are population averages, and individual trajectories vary enormously. A 55-year-old with good kidney function, controlled blood sugar, and access to a vascular team is in a fundamentally different position from a 75-year-old on dialysis with advanced heart disease. Frailty scores, kidney function, and the state of the blood vessels in the remaining leg are all more predictive than the amputation itself.
Some practical things worth knowing if you or someone you care about is facing this situation:
- Ask about revascularization: If blood flow to the leg is the problem, restoring that flow before or instead of amputation can change the trajectory. Not everyone is a candidate, but the question should always be asked.
- Push for team-based care: Multidisciplinary foot clinics reduce amputation rates and improve survival. If your hospital does not have one, it may be worth asking about referral to a center that does.
- Take rehabilitation seriously: Getting fitted with a prosthesis and staying mobile are associated with much better outcomes. Even when a prosthesis is not possible, structured rehabilitation and physical therapy help.
- Watch for depression: If mood drops after an amputation or in the lead-up to one, that is not just a quality-of-life concern. Depression is a risk factor for dying sooner, and treating it may materially improve outcomes.
- Protect the other foot: About a third of patients undergo a second amputation. Meticulous foot care, proper footwear, and regular inspection of the remaining foot can delay or prevent that second procedure.
The numbers are sobering, but they describe what happens on average, in populations that include many people who received fragmented or delayed care. The subset of patients who get early, coordinated, aggressive management of their vascular disease, kidney function, and wound care do considerably better than these averages suggest.